43,389 Shares in ProAssurance Co. (NYSE:PRA) Acquired by Susquehanna Fundamental Investments LLC

Susquehanna Fundamental Investments LLC purchased a new stake in ProAssurance Co. (NYSE:PRA - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 43,389 shares of the insurance provider's stock, valued at approximately $690,000. Susquehanna Fundamental Investments LLC owned about 0.08% of ProAssurance at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Arrowstreet Capital Limited Partnership raised its position in shares of ProAssurance by 92.1% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 690,871 shares of the insurance provider's stock worth $10,992,000 after acquiring an additional 331,224 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of ProAssurance by 4.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,703,953 shares of the insurance provider's stock valued at $43,019,000 after acquiring an additional 123,232 shares in the last quarter. Brandywine Global Investment Management LLC purchased a new position in shares of ProAssurance during the 4th quarter worth $1,654,000. JPMorgan Chase & Co. grew its position in shares of ProAssurance by 28.0% during the fourth quarter. JPMorgan Chase & Co. now owns 323,955 shares of the insurance provider's stock valued at $5,154,000 after purchasing an additional 70,780 shares in the last quarter. Finally, Wakefield Asset Management LLLP purchased a new position in shares of ProAssurance during the 4th quarter worth about $1,036,000. Institutional investors and hedge funds own 85.58% of the company's stock.

ProAssurance Stock Performance

PRA traded down $0.01 on Thursday, hitting $22.95. 159,059 shares of the company's stock were exchanged, compared to its average volume of 432,724. ProAssurance Co. has a twelve month low of $10.76 and a twelve month high of $23.70. The stock has a fifty day moving average of $21.18 and a two-hundred day moving average of $17.55. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.35. The firm has a market cap of $1.17 billion, a PE ratio of 27.65 and a beta of 0.04.

ProAssurance (NYSE:PRA - Get Free Report) last issued its earnings results on Tuesday, May 6th. The insurance provider reported $0.13 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.19 by ($0.06). ProAssurance had a return on equity of 2.65% and a net margin of 3.71%. The company had revenue of $236.28 million for the quarter, compared to the consensus estimate of $272.85 million. During the same quarter last year, the business posted $0.08 EPS. ProAssurance's quarterly revenue was down 4.5% on a year-over-year basis. On average, research analysts anticipate that ProAssurance Co. will post 0.8 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

PRA has been the topic of several recent research reports. Citizens Jmp cut shares of ProAssurance from an "outperform" rating to a "market perform" rating in a research report on Thursday, April 3rd. StockNews.com initiated coverage on ProAssurance in a research note on Saturday, May 3rd. They issued a "hold" rating on the stock. Citigroup cut shares of ProAssurance to a "market perform" rating in a research note on Thursday, April 3rd. Finally, Raymond James downgraded ProAssurance from a "market perform" rating to an "underperform" rating in a research report on Thursday, April 10th. One analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $18.67.

ProAssurance Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.